Search

everythinglearnresearchcommunity

for

Search:↓

New micelle nanocarriers deliver Tacrolimus more effectively to skin layers for psoriasis treatment than the current Protopic ointment.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

A simplified scoring system can effectively diagnose hirsutism in Chinese women of reproductive age.

Different types of skin cells are organized in a special way in large wounds to help with healing and hair growth.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Facial rejuvenation surgery makes people look younger, more attractive, successful, and healthy.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Reflectance confocal microscopy is a useful, non-invasive tool for diagnosing some skin diseases, with potential for future improvements.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Researchers found specific genes in the part of hair follicles that could help treat hair disorders.

New hair can grow from large wounds in mice, but less so as they age, involving reprogramming of skin cells and specific molecular pathways.

Long pulsed Nd: YAG laser is safe and effective for long-term hair reduction in darker skin types.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

The procedure safely and effectively lifted the lateral brow, improving appearance with minimal complications.

Maintain a natural, masculine look while rejuvenating the eye area with careful, tailored techniques.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Facial hair is crucial for transgender men's gender identity and transition.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Possible causes of female hair loss include androgenetic alopecia, telogen effluvium, cicatricial alopecia, and alopecia areata incognita; diagnosis and treatment require dermoscopy and histopathology.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

The study showed that some hair follicle stem cells wake up to grow hair while others stay asleep, and that the environment around them is important for hair growth.

Sox9 levels in brain stem cells affect whether they stay as stem cells or become neurons.

New techniques can effectively treat aging around the eyes.

Tofacitinib is an effective and safe treatment for alopecia areata.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.